发明人孙丽萍,何建平,郑宇鹏. "Method for the Synthesis of 5-Chloro-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}-1H-indole-2-carboxamide" [P]. 中国发明专利, 专利号 CN 110191823 B, 授权公告日 2019-02-28.
发明人黄志刚,赵玉洁,罗永刚. "A Process for Preparing High-Purity 5-Chloro-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}-1H-indole-2-carboxamide" [P]. 中国发明专利, 专利号 CN 114938255 A, 授权公告日 2019-02-17.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2023, 687, (2), 8481-8503.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2020, 360, 2657-2682.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 5-Chloro-N-{1-[3-(pyrazin-2-yl)-1,2,4-oxadiazol-5-yl]cyclohexyl}-1H-indole-2-carboxamide Using HRMS and NMR". J. Agric. Food Chem., 2018, 1907, (9), 9756-9781.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2021, 1020, (4), 3806-3815.